C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 38/19 (2006.01) A61P 29/00 (2006.01) A61P 31/00 (2006.01) A61P 37/00 (2006.01) C07K 19/00 (2006.01)
Patent
CA 2536082
Variants of homodimer-forming chemokines, such as human CCL2, having a single amino acid substitution in the dimerization interface that alters the pattern of hydrogen bonds and acting as an obligate monomer, can antagonize natural chemokines and have anti-inflammatory activity in vivo. These variants can be used as active ingredient in pharmaceutical compositions for the treatment of inflammatory, autoimmune, or infectious diseases.
L'invention concerne des variants de chemokines formant des homodimères, tels que CCL2 humain, qui comprennent une seule substitution acide aminé dans l'interface de dimérisation modifiant le motif de liaisons hydrogène et agissant comme un monomère obligatoire, peuvent avoir des chemokines naturelles pour antagonistes et une activité anti-inflammatoire in vivo. Ces variants peuvent être utilisés comme ingrédient actif dans des compositions pharmaceutiques pour traiter des maladies inflammatoires, auto-immunes ou infectieuses.
Johnson Zoe
Proudfoot Amanda
Shaw Jeffrey
Applied Research Systems Ars Holding N.v.
Kirby Eades Gale Baker
Merck Serono Sa
LandOfFree
Therapeutic uses of chemokine variants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic uses of chemokine variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of chemokine variants will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1855212